Biodegradable microspheres have been gathering attention as a promising controlled release drug delivery system (DDS), since they can administrate with one injection, dissolve in a body, release drugs over time, and do not need to remove after use. To produce microspheres with high throughput and high uniformity, flowfocusing microfluidic devices have been widely employed. Although softlithography technology is a simply way to replicate flow-focusing microfluidic devices, there has yet to be reported organic-solvent resistant, flowfocusing microfluidic devices mainly due to lack of organic-solvent resistant elastomers. Here, we establish a method to fabricate flow-focusing microfluidic device using fluoroelastomer, SIFEL. We stacked a vinyl silicone end group rich layer and a silicone hybrid end group rich layer to seal SIFEL microfluidic devices by using hydrosilylation between two layers. Then, by flowing chloroform, we experimentally verified that SIFEL microfluidic devices did not swell, whereas polydimethylsiloxane (PDMS) microfluidic device showed swelling. When we flowed polyvinyl alcohol (PVA) 1% aqueous solution flow in continuous phase and 1% poly lacticco-glycolic acid (PLGA) in chloroform flow in discontinuous phase, we obtained PGLA microspheres with diameter of 67.0±1.6 μm. Therefore, we envision that the SIFEL device can be a powerful tool for development of controlled-release DDS for water insoluble drugs.
Introduction
Controlled-release drug delivery system (DDS) can deliver drugs with controlled dosage for an extended time period. Thus, controlled-release DDS has advantages over other DDS mainly due to minimal side effects, decrease in the number of doses per day and improved drug compliance (Anderson and Shive, 2012) . In particular, controlled-release DDS using biodegradable materials does not need to remove after use, thus being able to remove an additional surgery. PLGA (poly (D,L-lactide-co-glycolide)) has been used for controlled DDS due to its biodegradability and high-biocompatibility (Langer and Peppas, 1983) . PLGA is polymer copolymerized with lactic acid and glycol through ester bonds. When PLGA is implanted to a body, PLGA is decomposed into lactic acid and glycol by hydrolysis and these are decomposed into water and carbon dioxide by the TCA cycle (tricarboxylic acid cycle) and discharged from a body (Chen et al., 2002) .
Among the various shapes of controlled release DDS, biodegradable microspheres have been employed because microspheres are injectable, minimally-invasive, and biocompatible. Size uniformity of microspheres help us easily control drug dosage, thus there have been effort to form microspheres with high-uniformity. The conventional method to form microsphere is emulsification; this process employs agitation of two immiscible liquids (continuous phase and dispersed phase) (O'Donnell and McGinity, 1997) . Despite of its simplicity, emulsification has barriers to control diameter of microspheres with high uniformity (Smith, 1986) . Variations in microsphere size can cause undesirable effects, such as the kinetics of drug release and instability of drug release dosage (Sansdrap and Moës, 1993) .
Alternately, flow-focusing microfluidic devices have been proposed to form microspheres with high uniformity and high throughput (Anna et al., 2003 continuous and discontinuous phases meet. At the cross-junction, continuous phase flow breaks discontinuous phase flow to droplets that turn into microspheres. Furthermore, flow-focusing microfluidic devices provide an easy way to control microsphere size; microsphere size can be easily changed by controlling flow rates (Xu et al., 2009; Yang et al., 2014; Kim et al., 2015) . Most flow-focusing microfluidic devices are made of well-known elastomer, polydimethylsiloxane (PDMS), via softlithography technology (Dendukuri et al., 2008) . PDMS has many superior characteristics, such as low production cost, high robustness, heat resisting properties, good transparency and high biocompatibility. Although PDMS-based devices show their potential to immobilize water-soluble drugs in microspheres, PDMS-based devices cannot apply to fabricate water-insoluble DDS mainly due to lack of organic solvent resistance (Lee et al., 2003) . We here propose a fabrication method of organic-solvent resistant flow-focusing microfluidic devices. We employ flouroelastomer, SIFEL, as device material. SIFEL is organic-solvent resistant, transparent, and compatible with softlithography. In this paper, we describe fabrication process of SIFLE-based devices, evaluate organic solvent resistance, and demonstrate microspheres formation, to verify potential of SIFEL as a new material of flow-focusing microfluidic devices.
Materials and methods

Materials
A epoxy-based negative photoresist (SU8-50) and a fluorinated coating (DURASURF, Primer coat+DS-5200) were purchased from MicroChem Corp. and HARVES Co., Ltd. Cover glass was purchased from Matsunami Glass Ind., Ltd. Reagents including chloroform, poly (D,L-lactide-co-glycolide) (PLGA, lactide/glycolide = 75/25, Mw = 66,000 -107,000 Da), and polyvinyl alcohol (PVA, Mw = 31,000 -50,000 87-89% hydrolyzed) were purchased from Sigma Chemical Co. A fluoroelastomer (SIFEL ® -X71 8115 kits (parts A&B)) was supplied from Shin-Etsu Chemical Co., Ltd. A silicone elastomer (Room Temperature Vulcanization silicone, RTV-615) was purchased from MOMETIVE.
Bonding methods of fluoroelastomer-based devices
We chemically bond fluoroelastomer (SIFEL)-based devices via hydrosilylation. SIFEL-X71 8115 are suggested to mix of A and B components in 1:1 ratio to cure. SIFEL is a fluoroelastomer with perfluoropolyether backbone. The perfluoroether backbone gives the polymer its chemical and solvent resistance. Figure 1 shows molecular structure of SIFEL (part A&B). The ends of backbone have silicone crosslinking groups (vinyl silicone (part A) and silicone hydride (part B)). When A and B components were mixed in 1:1 ratio and baked at ~120°C, then SIFEL cures by hydrosilylation reaction under conditions with Pt catalyst. The mechanism of curing is similar to RTV-615, which also cures by hydrosilylation reaction.
We bond SIFEL devices via hydrosilylation between a vinyl-rich SIFEL layer and a hydride-rich SIFEL layer. Such layer-to-layer of SIFEL bonding technique was described in previous work (Devaraju et al., 2011; Unger et al., 2001 ). When we stack a vinyl-rich SIFEL (part A-rich) layer and a hydride-rich SIFEL layer (part B-rich), and bake at 120°C for (Fig. 1) , hydrosilylation. RTV and SIFEL can also bond through hydrosilylation.
Device design and fabrication process
We here design flow-focusing devices with the microchannel width of 100 μm (Fig. 3a) . Ultimately, we would like to apply microspheres for drug delivery system (DDS). If microspheres are smaller than syringe needle, they can be injected to skin. Moreover, the size of implanted material affects to biocompatibility (Heo et al., 2013) . In previous report, if the material is sufficiently biocompatible, microspheres with diameter of ~100 μm are biocompatible under the skin (Shibata et al., 2010) . Therefore, to apply biocompatible PLGA microspheres for DDS, we aim to form PLGA microspheres with diameter of ~100 μm. We can form microspheres with diameter of ~100 μm in this design.
To obtain fluoroelastomer (SIFEL)-based microfluidic devices, first, we fabricated a mold master by patterning negative photoresist (SU-8 50, MicroChem, Ltd.) on a 2-inch silicon wafer. We used fluorine coater (DURASURF, DS-5200, HARVES Co. Ltd.) to form an antiadhesive layer on a mold master. Such layer helps polymer peel off from the mold master. We spin-coated primer to link epoxy-based photoresist (SU8) and fluorine coater, then spin-coated the fluorine coater. Such process makes florinated-chain-attached surface, which has antiadhesive property. After forming an antiadhesive layer on the mold master, we poured 1.5 g B-rich SIFEL (1:1.5, A:B), and depressurized in a desiccator to remove air bubbles for 30 min. Subsequently, we put the sample on a hotplate at 110 °C for 10 min to obtain a half-cured B-rich SIFEL layer. Then, we poured 8.8g RTV-615 on the SIFEL layer, and put the sample on a hotplate at 110 °C for 90 min. After cooling down to room temperature, the B-rich SIFEL-RTV sample was peeled off from the mold master. To connect to a syringe pump through tubes, we punched inlet and outlet holes to the sample. A-rich SIFEL (1.5:1, A:B) was spin-coated on a glass substrate and baked in an oven at 110 °C for 30 min. The B-rich SIFEL-RTV cured device was place on the A-rich SIFEL coated glass substrate. To increase bonding strength, we added the pressure of 3.4 kN/m 2 on the stacked layers. Lastly, we could obtain the microfluidic device after baking the sample in an oven at 120 °C for 45 min (Fig. 2) . To evaluate organic-solvent resistance, we made PDMS-based and SIFEL-based microfluidics devices with the same dimensions. Chloroform was filtered using filters (0.22 μm (MS PTFE Syringe Filter)) before use: such preparation can remove particles, thus preventing channel blocking and flow instability. We used syringe pumps (KDS-210, KD Scientific Inc.) to flow chloroform. Syringes were connected to microfluidics through teflon tubes that have organic-solvent resistance. Before flowing chloroform, we obtained photos of a cross-junction of PDMS and SIFEL microchannels using a camera-equipped inverted microscope (digital microscope camera, DFC450C, Leica, Germany; inverted microscope, DMI 4000B, Leica, Germany). We flow chloroform to three inlets and filled chloroform in microchannels. After 10 min, we obtained photos of a cross-junction of PDMS and SIFEL microchannels using a camera-equipped inverted microscope. We analyzed dimensions of microchannels using image processing program (ImageJ).
Evaluation of organic-solvent resistance
Biodegradable microsphere formation
We formed PLGA microspheres using the flow-focusing microfluidic device described in Fig. 3 . All reagents and distilled water were filtered using filters (chloroform: 0.22 μm (MS PTFE Syringe Filter), other reagents and water: 0.22μm (MILLEX-GP Filter Unit)) before use. Such filtration step helps us remove particles in liquids, thus preventing channel blocking and flow instability. We used two syringe pumps (KDS-210, KD Scientific Inc.) to flow two difference phases. Syringes were connect to inlets of a microfluidic device through teflon tubes that have organic-solvent resistance. We flowed the PLGA 1% wt/v in chloroform at flow rate of 5.5 μl/min into the central channel of the SIFEL flow-focusing device as a discontinuous phase and the PVA 1% wt/v in distilled water at flow rate of 50 μl/min into the two side channels of the flow-focusing device as a continuous phase. PVA dissolved in the continuous phase working as surfactant. Due to PVA, we could prevent PLGA microsphere aggregate at the downstream channel of the SIFEL flow-focusing microfluidic device and in the collecting container. We obtained photos of microsphere at downstream using a camera-equipped inverted microscope (digital microscope camera, DFC450C, Leica, Germany; inverted microscope, DMI 4000B, Leica, Germany). The dimeter of microspheres is estimated using image processing program (ImageJ). We estimated dimensions of 77 microspheres, and then analyze size distribution based on the coefficient of variation.
Evaluation of organic-solvent resistance
We experimentally verify organic solvent resistance of fluoroelastomer (SIFEL) by flowing chloroform in microchannels. We compared swelling of SIFEL and polydimethyl siloxane (PDMS) because PDMS is widely used for microfluidic devices. We flowed chloroform in the microchannels of SIFEL and PDMS for 10 min, and compared dimensions before and after flowing chloroform. At the right top of cross junction, a bubble was trapped and hindered device bonding. Since chloroform can easily permeate the gap between two unbonded layers, we measured shrinking ratio of microchannels at other portions. As describe in Fig 4, width of PDMS microchannels reduced to 69% by chloroform after 10 min because PDMS swells due to chloroform. Such result indicates that PDMS cannot maintain original pattern size due to its low chemical resistance. On the other hand, width of SIFEL microchannels did not reduce due to its chemical resistance to organic solvent, such as chloroform.
Microsphere formation
To demonstrate SIFEL potential of microfluidic applications, we designed flow-focusing microfluidic devices with a cross junction. In flow-focusing devices, the continuous phase stream focuses the discontinuous phase stream at first. This condition is jet stream. Then, the jet stream is broken into droplets. This mechanism can be classified into dripping and jetting (Utada et al., 2005) . The mechanism is defined by the capillary number of interface between the inner and the outer fluids. The mechanism transit from dripping to jetting at the capillary number of 1. In dripping, interfacial forces dominate over inertial forces, thus forming droplet close to a junction where two fluid meets. It has been known that we can produce monodisperse droplets under dripping condition (Morimoto et al., 2009 ). Thus, we aimed to form droplets under dripping condition. Then, fluid in discontinuous phase was broken by fluid in continuous phase. Droplets turned into microspheres. We employed PLGA in chloroform working as fluid of discontinuous phase, and PVA aqueous solution working as fluid of continuous phase. As a result, we could form PLGA microspheres using the present SIFEL device. Figure 5 (a) shows PLGA microsphere formation at the downstream channel. The obtained microspheres had diameter of 67.0±1.6 μm that shows small size distribution (Fig. 5(b) ). We fabricated microchannels with width of 101 μm and depth of 86 μm. To remove wetting issues that increase size distribution (Takeuchi et al., 2005) , we formed droplets smaller than channel dimensions. Since droplet radius is proportional to (Q OF /Q IF +1) -1/2 (Morimoto et al., 2009) , we controlled flow rates to obtain a particular microsphere size. The coefficient of variation of microsphere diameters was 2.34%; such Figure 4 . PDMS and SIFEL microchannels before and after 10 min from flowing chloroform. PDMS microchannel showed shrinking ratio of 0.69 due to lack of organic-solvent resistance, whereas SIFEL microchannel showed no swelling due to chloroform. value of coefficient of variation well matches to ability of droplet formation in microfluidic devices (CV<5%) (Takeuchi et al., 2005) . These results also correspond to the results in chapter 2; SIFEL-based devices do not swell due to chloroform, thereby enabling to form droplets with high uniformity. The droplet size is related to channel area and ratio of outer and inner flow rates (Morimoto et al., 2009): (1) R drop , A channel, Q OF , and Q IF are droplet radius, channel area, flow rates of outer fluid and inner fluid, respectively. The size distribution is mainly originated from channel dimensions and ratio of outer and inner flow rates. When we flowed chloroform to PDMS microfluidic devices, channel width reduced to 69% after 10 min. If the ratio of flow rates are the same, droplet radius will reduce to 69% (1). However, when we flowed chloroform to SIFEL microfluidic devices, microchannel dimensions did not change, thus droplet radius will not change as time passes. Since microfluidic flowfocusing devices can produce monodisperse droplets at a high frequency (~10 ) and SIFEL does not swell by chloroform for 24 h (Renckens et al., 2011) , we envision that the SIFEL-based flow-focusing devices can produce monodisperse microspheres with high-uniformity and high-throughput for a long-term. Although the present SIFEL devices can fabricate microspheres with sufficiently high uniformity, we can further reduce size distribution by stabilizing flow rates. For example, when we have long microchannels before cross junction, flow rates can stabilize by passing the microchannels; this approach can lead the smaller size distribution.
Conclusions
This study proposed a new type of flow-focusing devices that have organic solvent resistance. We fabricated flowfocusing devices using new softlithography material, SIFEL. SIFEL did not swell by chloroform whereas PDMS swelled. Due to its organic solvent resistance, SIFEL-based flow-focusing devices could maintain device dimensions, consequently forming droplets dissolved in organic solvent with high uniformity. Provided that further technical refinement (e.g., optimization of device design) is conducted, SIFEL-based flow-focusing devices can provide a new route to obtain micro drug delivery system for water-insoluble drugs.
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